| Literature DB >> 35134347 |
Angeleen Fleming1, Mathieu Bourdenx2, Motoki Fujimaki3, Cansu Karabiyik3, Gregory J Krause4, Ana Lopez1, Adrián Martín-Segura4, Claudia Puri3, Aurora Scrivo4, John Skidmore5, Sung Min Son3, Eleanna Stamatakou3, Lidia Wrobel3, Ye Zhu3, Ana Maria Cuervo6, David C Rubinsztein7.
Abstract
The term autophagy encompasses different pathways that route cytoplasmic material to lysosomes for degradation and includes macroautophagy, chaperone-mediated autophagy, and microautophagy. Since these pathways are crucial for degradation of aggregate-prone proteins and dysfunctional organelles such as mitochondria, they help to maintain cellular homeostasis. As post-mitotic neurons cannot dilute unwanted protein and organelle accumulation by cell division, the nervous system is particularly dependent on autophagic pathways. This dependence may be a vulnerability as people age and these processes become less effective in the brain. Here, we will review how the different autophagic pathways may protect against neurodegeneration, giving examples of both polygenic and monogenic diseases. We have considered how autophagy may have roles in normal CNS functions and the relationships between these degradative pathways and different types of programmed cell death. Finally, we will provide an overview of recently described strategies for upregulating autophagic pathways for therapeutic purposes.Entities:
Mesh:
Year: 2022 PMID: 35134347 PMCID: PMC8930707 DOI: 10.1016/j.neuron.2022.01.017
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173